Centrica plc (LON:CNA – Get Free Report) insider Amber Rudd bought 1,624 shares of the stock in a transaction dated Monday, November 25th. The stock was bought at an average price of GBX 123 ($1.56) per share, with a total value of £1,997.52 ($2,532.35).
Amber Rudd also recently made the following trade(s):
- On Friday, October 25th, Amber Rudd purchased 1,635 shares of Centrica stock. The stock was bought at an average price of GBX 122 ($1.55) per share, with a total value of £1,994.70 ($2,528.78).
- On Wednesday, September 25th, Amber Rudd acquired 1,668 shares of Centrica stock. The shares were purchased at an average price of GBX 119 ($1.51) per share, for a total transaction of £1,984.92 ($2,516.38).
Centrica Price Performance
Shares of CNA stock opened at GBX 126.10 ($1.60) on Thursday. The firm has a fifty day simple moving average of GBX 120.03 and a 200-day simple moving average of GBX 128.98. The company has a market capitalization of £6.54 billion, a PE ratio of 571.59, a price-to-earnings-growth ratio of 0.45 and a beta of 1.08. Centrica plc has a twelve month low of GBX 112.99 ($1.43) and a twelve month high of GBX 157.90 ($2.00). The company has a current ratio of 1.77, a quick ratio of 0.40 and a debt-to-equity ratio of 61.65.
Centrica Company Profile
Centrica plc operates as an integrated energy company in the United Kingdom, Ireland, Scandinavia, North America, and internationally. The company operates through British Gas Services & Solutions, British Gas Energy, Centrica Business Solutions, Bord Gáis Energy, Centrica Energy, and Upstream segments.
Featured Stories
- Five stocks we like better than Centrica
- Using the MarketBeat Stock Split Calculator
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Where to Find Earnings Call Transcripts
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Centrica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centrica and related companies with MarketBeat.com's FREE daily email newsletter.